
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11928591
[patent_doc_number] => 09795569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Pharmaceutical soft gelatin capsule dosage form with modified guar gum'
[patent_app_type] => utility
[patent_app_number] => 14/210680
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6059
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210680
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210680 | Pharmaceutical soft gelatin capsule dosage form with modified guar gum | Mar 13, 2014 | Issued |
Array
(
[id] => 12015850
[patent_doc_number] => 09808539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Hypoosmotic solutions for lymph node detection'
[patent_app_type] => utility
[patent_app_number] => 14/202178
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3774
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14202178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/202178 | Hypoosmotic solutions for lymph node detection | Mar 9, 2014 | Issued |
Array
(
[id] => 9568801
[patent_doc_number] => 20140186515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'DUAL DRUG DOSAGE FORMS WITH IMPROVED SEPARATION OF DRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/199972
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4801
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199972
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/199972 | Dual drug dosage forms with improved separation of drugs | Mar 5, 2014 | Issued |
Array
(
[id] => 9568555
[patent_doc_number] => 20140186268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'Oxide Ferrimagnetics with Spinel Structure Nanoparticles and Iron Oxide Nanoparticles, Biocompatible Aqueous Colloidal Systems Comprising Nanoparticles, Ferriliposomes, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/172401
[patent_app_country] => US
[patent_app_date] => 2014-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21453
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14172401
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/172401 | Oxide Ferrimagnetics with Spinel Structure Nanoparticles and Iron Oxide Nanoparticles, Biocompatible Aqueous Colloidal Systems Comprising Nanoparticles, Ferriliposomes, and Uses Thereof | Feb 3, 2014 | Abandoned |
Array
(
[id] => 9510998
[patent_doc_number] => 20140147489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'RAPIDLY DISSOLVING FILM FOR DELIVERY OF AN ACTIVE AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/171612
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8066
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171612
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171612 | Rapidly dissolving film for delivery of an active agent | Feb 2, 2014 | Issued |
Array
(
[id] => 9641814
[patent_doc_number] => 20140219926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy'
[patent_app_type] => utility
[patent_app_number] => 14/171567
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6742
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171567 | Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy | Feb 2, 2014 | Abandoned |
Array
(
[id] => 13276713
[patent_doc_number] => 10149922
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-12-11
[patent_title] => Engineered collagen matrices for myocardial therapy
[patent_app_type] => utility
[patent_app_number] => 14/168826
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11186
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168826
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/168826 | Engineered collagen matrices for myocardial therapy | Jan 29, 2014 | Issued |
Array
(
[id] => 11901094
[patent_doc_number] => 09770514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Tamper-resistant pharmaceutical dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/157658
[patent_app_country] => US
[patent_app_date] => 2014-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8881
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14157658
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/157658 | Tamper-resistant pharmaceutical dosage forms | Jan 16, 2014 | Issued |
Array
(
[id] => 10380528
[patent_doc_number] => 20150265535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/440058
[patent_app_country] => US
[patent_app_date] => 2013-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7527
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440058 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Dec 26, 2013 | Abandoned |
Array
(
[id] => 10444251
[patent_doc_number] => 20150329264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PACKAGING'
[patent_app_type] => utility
[patent_app_number] => 14/758329
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9370
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758329 | PACKAGING | Dec 25, 2013 | Abandoned |
Array
(
[id] => 9421296
[patent_doc_number] => 20140105947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'NATURAL ESTER, WAX OR OIL TREATED PIGMENT, PROCESS FOR PRODUCTION THEREOF, AND COSMETIC MADE THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 14/110000
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3811
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110000
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110000 | NATURAL ESTER, WAX OR OIL TREATED PIGMENT, PROCESS FOR PRODUCTION THEREOF, AND COSMETIC MADE THEREWITH | Dec 17, 2013 | Abandoned |
Array
(
[id] => 9366890
[patent_doc_number] => 20140076763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Peelable Pouch for Transdermal Patch and Method for Packaging'
[patent_app_type] => utility
[patent_app_number] => 14/090502
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9436
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/090502 | Peelable pouch for transdermal patch and method for packaging | Nov 25, 2013 | Issued |
Array
(
[id] => 9363792
[patent_doc_number] => 20140073665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'MODIFIED RELEASE COMPOSITIONS COMPRISING TACROLIMUS'
[patent_app_type] => utility
[patent_app_number] => 14/079414
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24444
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14079414
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/079414 | Modified release compositions comprising tacrolimus | Nov 12, 2013 | Issued |
Array
(
[id] => 9339691
[patent_doc_number] => 20140066473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'MODIFIED RELEASE COMPOSITIONS COMPRISING TACROLIMUS'
[patent_app_type] => utility
[patent_app_number] => 14/079443
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24456
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14079443
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/079443 | Modified release compositions comprising tacrolimus | Nov 12, 2013 | Issued |
Array
(
[id] => 9338443
[patent_doc_number] => 20140065225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'Modified release compositions comprising tacrolimus'
[patent_app_type] => utility
[patent_app_number] => 14/079466
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24446
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14079466
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/079466 | Modified release compositions comprising tacrolimus | Nov 12, 2013 | Issued |
Array
(
[id] => 9330200
[patent_doc_number] => 20140056982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids'
[patent_app_type] => utility
[patent_app_number] => 14/069753
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5026
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069753
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069753 | Enhanced Carriers For The Delivery of Microparticles To Bodily Tissues And Fluids | Oct 31, 2013 | Abandoned |
Array
(
[id] => 9331080
[patent_doc_number] => 20140057862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF'
[patent_app_type] => utility
[patent_app_number] => 14/069233
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25294
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14069233
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/069233 | Formulations of histone deacetylase inhibitor and uses therof | Oct 30, 2013 | Issued |
Array
(
[id] => 9306114
[patent_doc_number] => 20140044788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Solid Oral Formulations of a Pyridopyrimidinone'
[patent_app_type] => utility
[patent_app_number] => 14/059925
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3629
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059925 | Solid Oral Formulations of a Pyridopyrimidinone | Oct 21, 2013 | Abandoned |
Array
(
[id] => 9307600
[patent_doc_number] => 20140046274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'PIROXICAM-CONTAINING MATRIX PATCHES AND METHODS FOR THE TOPICAL TREATMENT OF ACUTE AND CHRONIC PAIN AND INFLAMMATION THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 14/059375
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19751
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059375
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059375 | PIROXICAM-CONTAINING MATRIX PATCHES AND METHODS FOR THE TOPICAL TREATMENT OF ACUTE AND CHRONIC PAIN AND INFLAMMATION THEREWITH | Oct 20, 2013 | Abandoned |
Array
(
[id] => 9736123
[patent_doc_number] => 20140271834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Doxycycline Formulations, and Methods of Treating Rosacea'
[patent_app_type] => utility
[patent_app_number] => 14/055659
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7817
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055659
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/055659 | Doxycycline Formulations, and Methods of Treating Rosacea | Oct 15, 2013 | Abandoned |